Pathology News
editor

About Editor

This author has not yet filled in any details.
So far Editor has created 933 blog entries.

April 2026

Lumito and OracleBio Initiate a Pilot Project to Explore the Combination of High-sensitivity Tissue Imaging and Advanced Image Analysis

2026-04-13T08:25:39+00:00

Lumito AB and OracleBio today announce that a joint pilot project has been initiated. The purpose of the project is to explore the combination of Lumito’s high-sensitivity platform for tissue labelling and digital imaging with OracleBio’s expertise in quantitative image analysis. The pilot project is fully aligned with Lumito’s strategy to collaborate with established and specialised [...]

Lumito and OracleBio Initiate a Pilot Project to Explore the Combination of High-sensitivity Tissue Imaging and Advanced Image Analysis2026-04-13T08:25:39+00:00

Resilience and Reinvention: Biotech’s Year of Maturity

2026-04-07T11:07:51+00:00

From capital scarcity to clinical impact, execution and partnerships are redefining the industry’s next chapter. In early 2026, a handful of biotech financings quietly signaled something the industry had been waiting for. Companies like Aktis Oncology, Eikon Therapeutics, and Generate Biomedicines collectively raised more than a billion dollars within weeks. The capital did not flood [...]

Resilience and Reinvention: Biotech’s Year of Maturity2026-04-07T11:07:51+00:00

Leica Biosystems and Indica Labs Expand Digital Pathology-Powered Diagnostics in the USA with Aperio HALO AP DX Software Launch

2026-10-05T09:24:23+00:00

Leica Biosystems, a Danaher company and a global leader in anatomic and digital pathology solutions, and Indica Labs, a global leader in artificial intelligence (AI)-powered digital pathology software, launches Aperio HALO AP DX image management system designed for use with the Aperio GT 450 DX scanner. Together, the Aperio HALO AP DX software and the Aperio GT 450 DX scanner provide a [...]

Leica Biosystems and Indica Labs Expand Digital Pathology-Powered Diagnostics in the USA with Aperio HALO AP DX Software Launch2026-10-05T09:24:23+00:00

Integrating Ultrasound and Clinicopathologic Characteristics to Predict the Invasive Papillary Thyroid Carcinoma Among Indeterminate Thyroid Nodules

2026-04-07T11:01:53+00:00

The following abstract is drawn from a recently published paper in Dovepress: Cancer Management and Research Journal. We invite you to read the full paper and join the conversation, become a member of the Pathology News community to share your thoughts, ask questions, and engage with others around this work. Authors: Minfang Yao1,2 Zheng Zhang1 Zheng Hua1 [...]

Integrating Ultrasound and Clinicopathologic Characteristics to Predict the Invasive Papillary Thyroid Carcinoma Among Indeterminate Thyroid Nodules2026-04-07T11:01:53+00:00

Global Lung Cancer Diagnostics Market Led by Roche, Thermo Fisher with North America Driving Precision Growth

2026-04-02T08:53:26+00:00

Lung Cancer Diagnostics Market advances with early detection tech, biomarker testing, and rising demand for precision oncology solutions. In the high-stakes landscape of oncology, time is the only variable that cannot be recovered. As global healthcare systems shift from reactive treatment to Early-Detection Paradigms, the ability to identify pulmonary malignancies at Stage 0 or 1 [...]

Global Lung Cancer Diagnostics Market Led by Roche, Thermo Fisher with North America Driving Precision Growth2026-04-02T08:53:26+00:00

How Can Digital Pathology Workflows Stay Compliant and Efficient

2026-04-02T08:02:59+00:00

Digital pathology is revolutionizing diagnostics—but how do labs ensure compliance while maintaining efficiency? In this episode, I sit down with Scott Randall from Hamamatsu (Hamamatsu NanoZoomer) and Amanda Coble from Proscia (Proscia’s Website) to discuss how pathologists, lab professionals, and digital pathology vendors can navigate regulatory challenges while improving workflow efficiency. Scott and Amanda share their experiences in gaining FDA clearance for digital pathology solutions, discussing [...]

How Can Digital Pathology Workflows Stay Compliant and Efficient2026-04-02T08:02:59+00:00

March 2026

Multi-Modal Pathology-Radiology Fusion Market Predicted to Grow at a 14.3% CAGR from 2026 to 2030

2026-04-01T09:46:14+00:00

The Business Research Company’s Multi-Modal Pathology-Radiology Fusion Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 The fusion of pathology and radiology through multi-modal technologies is transforming healthcare diagnostics and treatment plans. As this innovative approach gains traction, understanding its current market landscape and the factors propelling its growth becomes essential. Let’s explore [...]

Multi-Modal Pathology-Radiology Fusion Market Predicted to Grow at a 14.3% CAGR from 2026 to 20302026-04-01T09:46:14+00:00

Beyond the Manuscript: How Social Media Is Redefining the Modern Oncologist

2026-04-01T09:00:29+00:00

Author: Ariana Pelosci Today the patient-physician relationship that Pergament et al outlined in 1999 is even more prevalent, driven by the rapid development, use, and uptake of social media across all oncology fronts. In 1983, the internet as we know it today and its commercial-use capacity were born.1 Occurring just 4 years before the launch [...]

Beyond the Manuscript: How Social Media Is Redefining the Modern Oncologist2026-04-01T09:00:29+00:00

Global Melanoma Cancer Diagnostics Market Led by Roche, Bristol Myers with North America Driving Growth

2026-04-01T08:19:28+00:00

Melanoma Cancer Diagnostics Market grows with rising skin cancer cases, AI diagnostics, and demand for early, accurate detection solutions. In the critical timeline of skin cancer treatment, the transition from suspicion to diagnosis is the most vital window for patient survival. As global dermatology shifts toward Non-Invasive Molecular Profiling and AI-Enhanced Screening, the ability to [...]

Global Melanoma Cancer Diagnostics Market Led by Roche, Bristol Myers with North America Driving Growth2026-04-01T08:19:28+00:00

Integrated Single-Cell and Spatial Transcriptomics Analysis Reveals Potential Therapeutic Targets in Pancreatic Cancer 

2026-03-30T09:09:27+00:00

by Christos Evangelou, MSc, PhD – Medical Writer and Editor Neural invasion occurs in 80%-100% of patients with pancreatic ductal adenocarcinoma (PDAC) and is an independent predictor of poor prognosis. However, the cellular mechanisms underlying neural invasion remain unknown. In a recent study, researchers at the Shenzhen Bay Lab, Peking University, Guangdong Provincial People's Hospital, and Chongqing Medical University in China used cutting-edge single-cell and [...]

Integrated Single-Cell and Spatial Transcriptomics Analysis Reveals Potential Therapeutic Targets in Pancreatic Cancer 2026-03-30T09:09:27+00:00
Legal

Bioincyte Ltd is registered in the United Kingdom
under company number 13037659

Get in touch

© Copyright 2025, Bioincyte Ltd

Fields marked with an asterisk (*) are required.
By submitting you agree to our T&C and Privacy Policy

Go to Top